The following meetings are scheduled for the months ahead:
1998 FDA Science Forum on Biotechnology: The FDA, Sigma Xi, and American Association of Pharmaceutical Scientists (AAPS) are cosponsoring a conference entitled "1998 FDA Science Forum on Biotechnology: Advances, Applications and Regulatory Challenges" on December 8-9, 1998, at the Washington, DC, Convention Center. The preliminary agenda includes sessions on "biofarming/biopharming"; microbial pathogens; antibiotics and resistance; therapeutic and preventive agents; diagnostics and detection methods; and new models/methods for safety assessment.
Further information is available from AAPS by telephone at (703) 548-3000 or by e-mail at meetings@aaps.org. Internet site: http://www.aaps.org/edumeet.html.
FDA-NCI Workshop on Tumor Vaccines: The FDA and the National Cancer Institute are cosponsoring a workshop on December 10-11, 1998, at Masur Auditorium, National Institutes of Health, Bethesda, Md. The agenda includes sessions on regulatory considerations in tumor vaccines, phenotypic and functional characterization of dendritic cells or other antigen-presenting cells, autologous . . . [Full Text of this Article]
